Ann: Appendix 4E & Preliminary Final Report, page-29

yep spot on, I think it’s the pricing and the possibility of cloud based imaging and reporting, which may reduce costs, that is making me interested.
Pme and intelerad can’t really price low in latam and then try to gouge in the us and aus. I’d be surprised if ime make any significant progress in aus but not impossible as a second line cheaper offering.

Latam on on its own still would be a pretty good market (then add in other developing countries and the market is still v significant.

Things like mpr mip and cross referencing are definitely basic but at 25% of the cost ime can afford to be behind the development curve so don’t let me put you off.